Daniel Risinger

Allergan, Inc.'s (NYSE: AGN) acquisition by Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is looking less likely, in light of a recent move by activist investor Bill Ackman, an analyst said Wednesday. Ackman made a "concession of defeat" in efforts to engineer an Allergan takeover...